Glut1 deficiency syndrome and novel ketogenic diets

Journal of Child Neurology

Volumn 28, Issue 8, 2013, Pages 1045-1048

  Klepper, Joerg ^a   Leiendecker, Baerbel ^b  

^a KLINIKUM ASCHAFFENBURG   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Glut1 deficiency syndrome; intractable childhood epilepsy; ketogenic diet; low glycemic index treatment; modified Atkins diet

Indexed keywords

GLUCOSE TRANSPORTER 1; KETONE; MEDIUM CHAIN TRIACYLGLYCEROL;

ATKINS DIET; BRAIN METABOLISM; CONFERENCE PAPER; DIET THERAPY; GLUCOSE TRANSPORTER 1 DEFICIENCY SYNDROME; KETOACIDOSIS; KETOGENIC DIET; PRIORITY JOURNAL; PROTEIN DEFICIENCY;

EID: 84880852464     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073813487600     Document Type: Conference Paper

References (18)

1. Kossoff EH, Freeman JM, Turner Z, Rubenstein JE Ketogenic Diets: Treatments for Epilepsy and Other Disorders. 5 th ed. New York NY: Demos Medical; 2011. New York NY: Demos Medical ; 2011:
2. Miranda MJ, Turner Z, Magrath G. Alternative diets to the classical ketogenic diet-can we be more liberal?. Epilepsy Res. 2012 ; 100: 278-285
3. Klepper J. GLUT1 deficiency syndrome in clinical practice. Epilepsy Res. 2012 ; 100: 272-277
4. De Vivo DC, Trifiletti RR, Jacobson RI, et al. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med. 1991 ; 325: 703-709
5. Kim DW, Kang HC, Park JC, Kim HD. Benefits of the nonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics. 2004 ; 114: 1627-1630
6. Schon H, Gelpke W, Lippach I.. [Metabolic studies with a mixed glyceride of fatty acids with medium chain length. I. Investigations on the utilization of mixed glycerides in intestine & on the urinary excretion of etherless acids]. Gastroenterologia. 1959 ; 91: 89-108
7. Schon H, Lippach I, Gelpke W. [Metabolic studies with a mixed glyceride of middle-chain fatty acids. II. Investigations on the changes of ketone-body content of blood & urine after the administration of the mixed glycerides]. Gastroenterologia. 1959 ; 91: 199-213
8. Huttenlocher PR, Wilbourn AJ, Signore JM. Medium-chain triglycerides as a therapy for intractable childhood epilepsy. Neurology. 1971 ; 21: 1097-1103
9. Liu YM. Medium-chain triglyceride (MCT) ketogenic therapy. Epilepsia. 2008 ; 49 (suppl 8). 33-36
10. Neal EG, Chaffe H, Schwartz RH. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia. 2009 ; 50: 1109-1117
11. Kossoff EH, McGrogan JR, Bluml RM. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia. 2006 ; 47: 421-424
12. Kossoff EH, Turner Z, Bluml RM, et al. A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav. 2007 ; 10: 432-436
13. Pfeifer HH, Thiele EA. Low-glycemic-index treatment: a liberalized ketogenic diet for treatment of intractable epilepsy. Neurology. 2005 ; 5: 1810-1812
14. Pfeifer HH, Lyczkowski DA, Thiele EA. Low glycemic index treatment: implementation and new insights into efficacy. Epilepsia. 2008 ; 49 (suppl 8). 42-45
15. Leen WG, Klepper J, Verbeek MM, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain. 2010 ; 133: 655-670
16. Ito Y, Oguni H, Ito S, et al. A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol. 2011 ; 53: 658-663
17. Kitamura Y, Okumura A, Hayashi M, et al. Oxidative stress markers and phosphorus magnetic resonance spectroscopy in a patient with GLUT1 deficiency treated with modified Atkins diet. Brain Dev. 2012 ; 34 (5). 372-375
18. Klepper J, Leiendecker B. Ketogenic diet for intractable childhood epilepsy. Monatsschr Kinderheilkd. 2011 ; 159: 739-744